The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
38
No.
17
April 27, 2012
CCL
Vol.
35
No.
4
April 27, 2012
- Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40
- ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients
- Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival
- Researchers Link Cancer Risk And DMPA Birth Control Use
- Breast-Conserving Procedures Lead To Frequent Follow-up Care
- False-Positive Mammograms Can Indicate Higher Cancer Risk
- Proposed Surveillance Model Aims To Reduce Post-Treatment Pain
- Adding Avastin Did Not Improve Standard Chemotherapy Regimen
- Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas
- Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial
- Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options
- Translplants Not Best Choice in Subset of ALL Patients
- PET Response Can Predict Increased Survival In Patients
- Cancer Incidence Rates Climb In HIV-Positive Female Populations
- Technology Isolates and Recovers Circulating Liver Tumor Cells
- Survey Shows That One-Third Of Patients Are Undertreated
- Trials Approved by NCI CTEP For the Month of April
- FDA Approves Votrient For Soft Tissue Sarcomas
TCL
Vol.
38
No.
18
May 04, 2012